S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What analysts wanted out of Chewy stock is finally here
The truth about DocuSign's relevancy in today's world: Surprise
Henry Ford Would NEVER Have Seen This Coming (Ad)
SoFi expands ETF business with options-driven income fund
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What analysts wanted out of Chewy stock is finally here
The truth about DocuSign's relevancy in today's world: Surprise
Henry Ford Would NEVER Have Seen This Coming (Ad)
SoFi expands ETF business with options-driven income fund
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What analysts wanted out of Chewy stock is finally here
The truth about DocuSign's relevancy in today's world: Surprise
Henry Ford Would NEVER Have Seen This Coming (Ad)
SoFi expands ETF business with options-driven income fund
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What analysts wanted out of Chewy stock is finally here
The truth about DocuSign's relevancy in today's world: Surprise
Henry Ford Would NEVER Have Seen This Coming (Ad)
SoFi expands ETF business with options-driven income fund
Federal Trade Commission is investigating ExxonMobil's $60B deal to acquire a Texas oil company

Neovasc Stock Price, News & Analysis (TSE:NVC)

Today's Range
N/A
50-Day Range
C$1.78
C$1.78
52-Week Range
N/A
Volume
46,869 shs
Average Volume
111,876 shs
Market Capitalization
C$140.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NVC stock logo

About Neovasc Stock (TSE:NVC)

Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.


NVC Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Convert NovaCoin To Canadian Dollar
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Convert NovaCoin To United States Dollar
Convert NovaCoin To Sri Lankan Rupee
Convert NovaCoin To Mexican Peso
Convert NovaCoin To Bitcoin
Convert NovaCoin To Ethereum
Convert NovaCoin To Euro
Convert NovaCoin To Ukrainian Hryvnia
Convert NovaCoin To Georgian Lari
Convert NovaCoin To Iraqi Dinar
NVC Lighting Holding Ltd (2222)
Therma Bright Inc V.THRM
See More Headlines
Receive NVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$140.06 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Paul L. Geyer
    Independent Chairman of the Board
  • Fred Colen
    President, Chief Executive Officer
  • Christopher Clark
    Chief Financial Officer, Corporate Secretary
  • Brian McPherson
    Chief Operating Officer
  • Vicki Lee Bebeau
    Vice President - Clinical Affairs
  • Randy Lane
    Vice President - Research & Development
  • Alexei J. Marko
    Director
  • Jane H. Hsiao Ph.D. (Age 69)
    Independent Director
  • Douglas Glen Janzen
    Independent Director
  • William O'Neill (Age 61)
    Independent Director














NVC Stock Analysis - Frequently Asked Questions

Should I buy or sell Neovasc stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVC, but not buy additional shares or sell existing shares.
View NVC analyst ratings
or view top-rated stocks.

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Neovasc (NVCN), PPL (PPL), Ballard Power Systems (BLDP), (CPXX) (CPXX), 155675 (BLD.TO) (BLD), Dundee Precious Metals (DPM), Fc Global Realty (FCRE), Top Ships (TOPS) and Birchcliff Energy (BIR).

How do I buy shares of Neovasc?

Shares of NVC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NVC) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -